EA201791458A1 - Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта - Google Patents

Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта

Info

Publication number
EA201791458A1
EA201791458A1 EA201791458A EA201791458A EA201791458A1 EA 201791458 A1 EA201791458 A1 EA 201791458A1 EA 201791458 A EA201791458 A EA 201791458A EA 201791458 A EA201791458 A EA 201791458A EA 201791458 A1 EA201791458 A1 EA 201791458A1
Authority
EA
Eurasian Patent Office
Prior art keywords
diseases
treatment
pharmaceutical composition
gastrointestinal tract
sucralfate
Prior art date
Application number
EA201791458A
Other languages
English (en)
Other versions
EA032385B9 (ru
EA032385B1 (ru
Inventor
Ён Хо Джо
Джун Воо Лее
Original Assignee
Дэвон Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55169799&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201791458(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дэвон Фармасьютикал Ко., Лтд. filed Critical Дэвон Фармасьютикал Ко., Лтд.
Publication of EA201791458A1 publication Critical patent/EA201791458A1/ru
Publication of EA032385B1 publication Critical patent/EA032385B1/ru
Publication of EA032385B9 publication Critical patent/EA032385B9/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В настоящем изобретении предложена фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта, содержащая ранитидин, сукральфат и субцитрат висмута в качестве активных ингредиентов, и способ ее получения. Согласно настоящему изобретению при получении комбинированного препарата ранитидина, сукральфата и субцитрата висмута можно решить проблему, связанную с гигроскопичностью ранитидина, и повысить стабильность лекарственной формы и биодоступность лекарственных средств за счет регулирования размеров частиц сукральфата и субцитрата висмута.
EA201791458A 2015-01-30 2016-01-28 Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта EA032385B9 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20150015339 2015-01-30
KR1020150147513A KR101583452B1 (ko) 2015-01-30 2015-10-22 위장질환 치료용 의약 조성물
PCT/KR2016/000935 WO2016122226A2 (en) 2015-01-30 2016-01-28 A pharmaceutical composition for treating gastrointestinal diseases

Publications (3)

Publication Number Publication Date
EA201791458A1 true EA201791458A1 (ru) 2017-11-30
EA032385B1 EA032385B1 (ru) 2019-05-31
EA032385B9 EA032385B9 (ru) 2019-07-31

Family

ID=55169799

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791458A EA032385B9 (ru) 2015-01-30 2016-01-28 Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта

Country Status (19)

Country Link
EP (1) EP3250199A4 (ru)
JP (1) JP6419347B2 (ru)
KR (2) KR101583452B1 (ru)
CN (1) CN107205947B (ru)
AR (1) AR105413A1 (ru)
CL (1) CL2017001680A1 (ru)
CO (1) CO2017006222A2 (ru)
EA (1) EA032385B9 (ru)
EC (1) ECSP17038599A (ru)
GE (1) GEP20196941B (ru)
MA (1) MA41432A (ru)
MX (1) MX2017007567A (ru)
MY (1) MY195824A (ru)
PE (1) PE20171340A1 (ru)
PH (1) PH12017550051A1 (ru)
SA (1) SA517382016B1 (ru)
TW (1) TWI635859B (ru)
UA (1) UA116517C2 (ru)
WO (1) WO2016122226A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101988479B1 (ko) 2017-10-11 2019-09-24 (주)휴럼 리트세노라이드를 유효성분으로 하는 헬리코박터 파이로리 균주로부터 유래되는 위장질환 예방 및 치료용 약학 조성물
WO2019199134A1 (ko) * 2018-04-13 2019-10-17 주식회사 삼양바이오팜 레날리도마이드를 포함하는 약제학적 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
US4990610A (en) * 1988-08-25 1991-02-05 Applied Analytical Industries, Inc. Method for preparing high potency sucralfate
EP0403048A3 (en) * 1989-06-14 1991-01-30 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production
KR970006083B1 (ko) * 1992-01-22 1997-04-23 주식회사 대웅제약 위장질환 치료용 의약 조성물
ES2173183T3 (es) * 1994-04-26 2002-10-16 Chugai Pharmaceutical Co Ltd Procedimiento de preparacion de sucralfato granulado y fundido.
JPH0879097A (ja) * 1994-09-01 1996-03-22 Matsushita Electric Ind Co Ltd 携帯無線機
KR970006083A (ko) 1995-07-06 1997-02-19 한승준 자동차용 카울부의 와이어 고정장치 취부구조
AU8354498A (en) * 1997-08-25 1999-03-16 Procter & Gamble Company, The Combined preparations for treating upper gastrointestinal tract distress
CN1173698C (zh) 1999-06-21 2004-11-03 株式会社大熊制药 包含包衣的雷尼替丁、碱式柠檬酸铋和硫糖铝的对胃肠障碍具有治疗作用的可口服给药的药物制剂
JP2006076956A (ja) * 2004-09-10 2006-03-23 Taiyo Yakuhin Kogyo Kk 胃炎の治療・予防用配合剤
KR101617054B1 (ko) * 2008-07-01 2016-04-29 라이온 가부시키가이샤 고형내복제제
KR20110105223A (ko) * 2010-03-18 2011-09-26 일양약품주식회사 일라프라졸 및 수크랄페이트와 비스무스 제제의 혼합물을 함유하는 위장질환을 예방 또는 치료하기 위한 경구용 약제 조성물
KR20140072673A (ko) 2012-12-05 2014-06-13 (주)한국파비스제약 경구용 위장질환 치료를 위한 정제

Also Published As

Publication number Publication date
TWI635859B (zh) 2018-09-21
ECSP17038599A (es) 2017-09-29
KR20160094268A (ko) 2016-08-09
EP3250199A2 (en) 2017-12-06
MY195824A (en) 2023-02-22
SA517382016B1 (ar) 2021-03-18
AR105413A1 (es) 2017-10-04
CN107205947B (zh) 2020-05-22
KR101583452B1 (ko) 2016-01-11
EP3250199A4 (en) 2018-08-08
WO2016122226A2 (en) 2016-08-04
JP2018503672A (ja) 2018-02-08
MX2017007567A (es) 2017-10-19
CN107205947A (zh) 2017-09-26
TW201639559A (zh) 2016-11-16
UA116517C2 (uk) 2018-03-26
PH12017550051A1 (en) 2018-01-29
EA032385B9 (ru) 2019-07-31
CL2017001680A1 (es) 2018-01-12
PE20171340A1 (es) 2017-09-13
CO2017006222A2 (es) 2017-09-20
EA032385B1 (ru) 2019-05-31
JP6419347B2 (ja) 2018-11-07
KR101583452B9 (ko) 2022-05-02
WO2016122226A3 (en) 2016-09-15
GEP20196941B (en) 2019-01-10
BR112017013857A2 (pt) 2018-02-27
MA41432A (fr) 2017-12-05

Similar Documents

Publication Publication Date Title
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201792591A1 (ru) Фармацевтические препараты
EA202090098A1 (ru) Фармацевтические композиции терапевтически активных соединений
MX2013003635A (es) Compuestos de n-heteroarilo.
EA201691490A1 (ru) Фармацевтическая композиция, содержащая бринзоламид
EA201790949A1 (ru) Замещенные 2,4-диаминохинолины в качестве новых противораковых средств
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
EA201590797A1 (ru) Препараты с модифицированным высвобождением опрозомиба
CY1124893T1 (el) Φαρμακευτικο μeιγμα μαροπιταντης
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
EA201691231A1 (ru) Фармацевтические лекарственные формы
EA201791458A1 (ru) Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
EA201690395A1 (ru) Стабильная фармацевтическая композиция, содержащая бисопролол и рамиприл
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
TR201908937T4 (tr) P38 MAP kinazı inhibe eden indanil üre bileşikleri.
EA201500128A1 (ru) Педиатрические жидкие композиции для перорального введения, содержащие непадутант
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
PH12016502540A1 (en) Pharmaceutical dosage forms
MX2017005692A (es) Formulacion en polvo.
TH173727B (th) องค์ประกอบเภสัชภัณฑ์สำหรับรักษาโรคทางเดินอาหาร

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG TJ TM